Description
CJC-1295 + Ipamorelin Blend (5mg/5mg) — synergistic GH stack for research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
This blend combines CJC-1295 No DAC (Mod GRF 1-29) with Ipamorelin in a precise 1:1 ratio. The combination targets both GHRH and GHS-R1a receptors, allowing researchers to study synergistic effects on growth hormone secretion.
What the Research Shows
Research has examined combined GHRH/GHRP administration effects on GH pulse amplitude and frequency. Studies suggest synergistic rather than merely additive effects when targeting both receptor pathways.
The blend allows investigation of GH axis modulation through dual-receptor activation without the variability of separate preparations. Published literature supports enhanced GH release compared to single-peptide administration.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity for both components. No generic overseas certificates.
→ Full CJC-1295 NO DAC + Ipamorelin Blend (5mg + 5mg) Research Guide
Purity: ≥99% each component (HPLC)
Form: Lyophilised powder
CJC-1295 No DAC: 5mg
Ipamorelin: 5mg
Total: 10mg
Research: PubMed
▸ Australian university verified
▸ ≥99% purity both components
▸ Same-day dispatch from Sydney
▸ Accurate 1:1 ratio
Related Research and Resources
For research use only. Not for human consumption.




